Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Production of biopharmaceuticals and vaccines in plants via the chloroplast genome

View through CrossRef
AbstractTransgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation; heat stability; and absence of human pathogens. When therapeutic proteins are orally delivered, plant cells protect antigens in the stomach through bioencapsulation and eliminate the need for expensive purification and sterile injections, in addition to development of both systemic and mucosal immunity. Chloroplast genetic engineering offers several advantages, including high levels of transgene expression, transgene containment via maternal inheritance and multi‐gene expression in a single transformation event. Hyper‐expression of vaccine antigens against cholera, tetanus, anthrax, plague or canine parvovirus (4–31% of total soluble protein, tsp) in transgenic chloroplasts (leaves) or non‐green plastids (carrots, tomato), as well as the availability of antibiotic‐free selectable markers or the ability to excise selectable marker genes, facilitate oral delivery. Hyper‐expression of several therapeutic proteins, including human serum albumin (11.1% tsp), somatotropin (7% tsp), interferon‐gamma (6% tsp), anti‐microbial peptide (21.5% tsp), facilitates efficient and economic purification. Also, the presence of chaperones and enzymes in chloroplasts facilitate assembly of complex multi‐subunit proteins and correct folding of human blood proteins with proper disulfide bonds. Functionality of chloroplast‐derived vaccine antigens and therapeutic proteins has been demonstrated by several assays, including the macrophage lysis assay, GM1‐ganglioside binding assay, protection of HeLa cells or human lung carcinoma cells against encephalomyocarditis virus, systemic immune response, protection against pathogen challenge, and growth or inhibition of cell cultures. Thus, transgenic chloroplasts are ideal bioreactors for production of functional human and animal therapeutic proteins in an environmentally friendly manner.
Title: Production of biopharmaceuticals and vaccines in plants via the chloroplast genome
Description:
AbstractTransgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation; heat stability; and absence of human pathogens.
When therapeutic proteins are orally delivered, plant cells protect antigens in the stomach through bioencapsulation and eliminate the need for expensive purification and sterile injections, in addition to development of both systemic and mucosal immunity.
Chloroplast genetic engineering offers several advantages, including high levels of transgene expression, transgene containment via maternal inheritance and multi‐gene expression in a single transformation event.
Hyper‐expression of vaccine antigens against cholera, tetanus, anthrax, plague or canine parvovirus (4–31% of total soluble protein, tsp) in transgenic chloroplasts (leaves) or non‐green plastids (carrots, tomato), as well as the availability of antibiotic‐free selectable markers or the ability to excise selectable marker genes, facilitate oral delivery.
Hyper‐expression of several therapeutic proteins, including human serum albumin (11.
1% tsp), somatotropin (7% tsp), interferon‐gamma (6% tsp), anti‐microbial peptide (21.
5% tsp), facilitates efficient and economic purification.
Also, the presence of chaperones and enzymes in chloroplasts facilitate assembly of complex multi‐subunit proteins and correct folding of human blood proteins with proper disulfide bonds.
Functionality of chloroplast‐derived vaccine antigens and therapeutic proteins has been demonstrated by several assays, including the macrophage lysis assay, GM1‐ganglioside binding assay, protection of HeLa cells or human lung carcinoma cells against encephalomyocarditis virus, systemic immune response, protection against pathogen challenge, and growth or inhibition of cell cultures.
Thus, transgenic chloroplasts are ideal bioreactors for production of functional human and animal therapeutic proteins in an environmentally friendly manner.

Related Results

Novel pathways for glycoprotein import into chloroplasts
Novel pathways for glycoprotein import into chloroplasts
SummaryAlthough the chloroplast contains its own genome, majority of its protein components are encoded by nuclear genes and must be imported post‐translationally. In general, prot...
Genome structure of incomplete particles of adenovirus
Genome structure of incomplete particles of adenovirus
Incomplete particles arising during productive growth of adenovirus were separated from infectious particles by density gradient centrifugation. The DNA contained in particles of l...
Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics
Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics
Abstract Susceptibility to HIV-1 and the clinical course after infection show a substantial heterogeneity between individuals. Part of this variability can be attributed ...
Light reacclimatization of lower leaves in C4 maize canopies grown at two planting densities
Light reacclimatization of lower leaves in C4 maize canopies grown at two planting densities
C4 plants have high photosynthetic capacity but are inefficient under low light. In a canopy, lower leaves developed under high light are progressively shaded. To elucidate how low...
Homo Electromagneticus II: Paradigms and Paradoxes
Homo Electromagneticus II: Paradigms and Paradoxes
Homo Electromagneticus is a musical performance realized in 2022 through a set of original instruments created with open-source and low-cost technologies. Arduino microcontrollers,...
Was Theocritus A Botanist?
Was Theocritus A Botanist?
Theocritus sings of eighty-seven different trees, shrubs, flowers, grasses, and ferns. Practically all the references are in the Pastoral Idylls: that is to say, that in the small ...
Cancer immunotherapy: potential involvement of mediators
Cancer immunotherapy: potential involvement of mediators
The description of a cell‐free soluble anti‐tumour factor by Carswell et al. in 1975 (Proc Natl Acad Sci USA, 72: 3666–3670) was followed by a long series of experimental and clini...

Back to Top